Your browser doesn't support javascript.
loading
節目: 20 | 50 | 100
结果 1 - 1 de 1
过滤器
添加過濾器








年份範圍
1.
文章 在 英语 | WPRIM | ID: wpr-149762

摘要

This study aimed to determine whether taurine supplementation improves metabolic disturbances and diabetic complications in an animal model for type 2 diabetes. We investigated whether taurine has therapeutic effects on glucose metabolism, lipid metabolism, and diabetic complications in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term duration of diabetes. Fourteen 50-week-old OLETF rats with chronic diabetes were fed a diet supplemented with taurine (2%) or a non-supplemented control diet for 12 weeks. Taurine reduced blood glucose levels over 12 weeks, and improved OGTT outcomes at 6 weeks after taurine supplementation, in OLETF rats. Taurine significantly reduced insulin resistance but did not improve beta-cell function or islet mass. After 12 weeks, taurine significantly decreased serum levels of lipids such as triglyceride, cholesterol, high density lipoprotein cholesterol, and low density lipoprotein cholesterol. Taurine significantly reduced serum leptin, but not adiponectin levels. However, taurine had no therapeutic effect on damaged tissues. Taurine ameliorated hyperglycemia and dyslipidemia, at least in part, by improving insulin sensitivity and leptin modulation in OLETF rats with long-term diabetes. Additional study is needed to investigate whether taurine has the same beneficial effects in human diabetic patients.


Subject(s)
Animals , Male , Rats , Adipokines/blood , Blood Glucose , Diabetes Mellitus, Type 2/drug therapy , Dietary Supplements , Dyslipidemias/blood , Glucose Tolerance Test , Hyperglycemia/blood , Hypoglycemic Agents/administration & dosage , Hypolipidemic Agents/administration & dosage , Insulin/physiology , Insulin Resistance , Insulin-Secreting Cells/physiology , Leptin/blood , Lipid Metabolism/drug effects , Lipids/blood , Organ Specificity , Rats, Long-Evans , Taurine/administration & dosage
搜索明细